A month has gone by since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. But investors have to be wondering, will ...
IDEXX Laboratories on Tuesday named insider Michael Erickson as its next chief executive officer and said incumbent Jonathan Mazelsky will retire in 2027. IDEXX raises annual forecasts on strong ...
IDEXX Laboratories continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, ...
IDEXX's business model relies on selling diagnostic equipment, consumables, veterinary software, and diagnostic imaging to generate recurring revenue. The company has experienced double-digit growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback